API reference
Methocarbamol
- CAS number
- 532-03-6
- Molecular formula
- C11H15NO5
- Molecular weight
- 241.24 g/mol
About this molecule
Methocarbamol was developed in the early 1950s as a treatment for muscle spasticity and the associated pain. It is a guaiacol glyceryl ether. Methocarbamol tablets and intramuscular injections are prescription medicines indicated in the United States as an adjunct to rest, physical therapy, and other measures for the relief of discomforts associated with acute, painful musculoskeletal conditions. In Canada, methocarbamol can be sold as an over the counter oral medicine at a lower dose that may be combined with [acetaminophen] or [ibuprofen]. A combination product with [acetylsalicylic acid] and [codeine] is available in Canada by prescription. Methocarbamol was FDA approved on 16 July 1957.
Source: DrugBank, via PubChem.
Identifiers
- IUPAC name
- [2-hydroxy-3-(2-methoxyphenoxy)propyl] carbamate
- InChIKey
- GNXFOGHNGIVQEH-UHFFFAOYSA-N
- SMILES
- COC1=CC=CC=C1OCC(COC(=O)N)O
- Other CAS numbers recorded
- 145841-69-6 · 3967-43-9
- PubChem CID
- 4107
Also known as
methocarbamol · Robaxin · Metocarbamol · Etroflex · Miolaxene · Miorilas · Relestrid · Surquetil
Chemical data on this page is drawn from PubChem (National Library of Medicine) and is provided for identification only. Hanpars does not hold stock of every substance listed; availability, grade, documentation and regulatory status are confirmed per enquiry.
Tell us the grade, the quantity and the market.
Send the molecule or ingredient, the specification and the destination. We reply from Tehran with the questions, the documents and the next step.